Novartis Announces New CTL019 Study Data Demonstrating Overall Response in Adults with Certain Types of Lymphoma at #ASH2015
December 06, 2015 at 08:43 AM EST
Findings from an ongoing Phase IIa study to evaluate the safety and efficacy of investigational chimeric antigen receptor T cell (CART) ...
